Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
Indoleamine 2,3-dioxygenase (IDO) is one of the initial rate-limiting enzymes of the kynurenine pathway (KP), which causes immune suppression and induction of T cell anergy. It is associated with the imbalance of immune homeostasis in numerous diseases including cancer, chronic viral infection, alle...
Enregistré dans:
Auteurs principaux: | Lingyan Xu, Jiawei Ling, Chang Su, Yu-Wen Su, Yan Xu, Zhenzhou Jiang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7eaba4b22cdc4ab29cedd65594f1d750 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling
par: Chih-Ta Chen, et autres
Publié: (2021) -
Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer
par: Sultan Tousif, et autres
Publié: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
par: V. A. Kozlov, et autres
Publié: (2017) -
Indoleamine 2,3-Dioxygenase Cannot Inhibit Chlamydia trachomatis Growth in HL-60 Human Neutrophil Granulocytes
par: Dezső P. Virok, et autres
Publié: (2021) -
Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase
par: Raghavan Chinnadurai, et autres
Publié: (2021)